HT
GWPH

HAP Trading’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

HAP Trading’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-89,800
Closed -$294K – 2766
2020
Q4 		$294K Buy
+89,800
New +$10.1M 0.01% 821
2019
Q3 		– Sell
-68,600
Closed -$64K – 1547
2019
Q2 		$64K Buy
+68,600
New +$11.9M ﹤0.01% 688
2017
Q2 		– Sell
-26,900
Closed -$46K – 1237
2017
Q1 		$46K Sell
26,900
-57,400
-68% -$7.04M ﹤0.01% 697
2016
Q4 		$67K Buy
84,300
+66,500
+374% +$8M ﹤0.01% 620
2016
Q3 		$417K Sell
17,800
-13,600
-43% -$1.3M 0.01% 396
2016
Q2 		$56K Buy
31,400
+17,100
+120% +$1.44M ﹤0.01% 592
2016
Q1 		$33K Buy
14,300
+3,000
+27% +$165K ﹤0.01% 583
2015
Q4 		$56K Buy
+11,300
New +$921K ﹤0.01% 625

Other funds holding GWPH

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HAP Trading's GWPH Position: Q2 2017 in Review

HAP Trading sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2017, closing a stake of 13,900 shares — an estimated $1.68M sold.

HAP Trading first reported a position in GWPH in Q4 2016 and held it in 2 quarters. The position peaked at $2.39M in Q4 2016. 170 funds tracked by Wall St. Rank hold GWPH as of Q2 2017.

  • HAP Trading reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2017 after selling out during the quarter.
  • HAP Trading sold 13,900 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2017, an estimated $1.68M.
  • HAP Trading first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2016 and held it in 2 quarters.
  • HAP Trading's GW Pharmaceuticals Plc American Depositary Shares position peaked at $2.39M in Q4 2016.
  • 170 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2017.

Based on HAP Trading's 13F filing for Q2 2017, filed 10 Aug 2017.